Quantification of Tc-99m Sestamibi Distribution in Normal Breast Tissue Using Dedicated Breast SPECT-CT

The use of Tc-99m-Sestamibi in molecular breast imaging is common due to its preferential uptake in malignant tissue. However, quantification of the baseline uptake in normal, healthy breast tissue is not possible using planar-imaging devices. Using our dedicated breast SPECT-CT system, an IRB approved pilot study is underway to quantify mean activity in normal breast tissue, and to differentiate uptake between adipose and glandular tissues. A cohort of patients at normal breast cancer risk undergoing another diagnostic Sestamibi study was imaged using the breast SPECT-CT system. SPECT images were corrected and quantitatively reconstructed using previously developed methods, and registered with the CT images. The CT images were segmented, and the average activity concentration was measured for glandular, adipose, and total breast tissue. Results indicate no preferential uptake between tissues and low average uptake, which may be used to determine a universal threshold for cancer detection.

[1]  Michael E Phelps,et al.  Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  Rachel F Brem,et al.  Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. , 2008, Radiology.

[3]  I. Mena,et al.  Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  Viviane,et al.  Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  M. Tornai,et al.  Evaluation of tilted cone-beam CT orbits in the development of a dedicated hybrid mammotomograph , 2009, Physics in medicine and biology.

[6]  James E. Bowsher,et al.  Evaluation of fully 3-D emission mammotomography with a compact cadmium zinc telluride detector , 2005, IEEE Transactions on Medical Imaging.

[7]  Martin P. Tornai,et al.  Development of in vivo characterization of breast tissues through absolute attenuation coefficients using dedicated cone-beam CT , 2010, Medical Imaging.

[8]  Towards quantification of dedicated breast SPECT using non-traditional acquisition trajectories , 2009, 2009 IEEE Nuclear Science Symposium Conference Record (NSS/MIC).

[9]  M S Rosenthal,et al.  Quantitative SPECT imaging: a review and recommendations by the Focus Committee of the Society of Nuclear Medicine Computer and Instrumentation Council. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  R. Jaszczak,et al.  Improved SPECT quantification using compensation for scattered photons. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  M. O’Connor,et al.  Quantification of lesion size, depth, and uptake using a dual-head molecular breast imaging system. , 2008, Medical physics.

[12]  Martin P Tornai,et al.  Evaluation of the absorbed dose to the breast using radiochromic film in a dedicated CT mammotomography system employing a quasi-monochromatic x-ray beam. , 2011, Medical physics.

[13]  Deborah Rhodes,et al.  Molecular breast imaging , 2009, Expert review of anticancer therapy.

[14]  E. Samei,et al.  Initial study of quasi-monochromatic X-ray beam performance for X-ray computed mammotomography , 2003, IEEE Transactions on Nuclear Science.

[15]  M. Tornai,et al.  Towards Quantification of Functional Breast Images Using Dedicated SPECT With Non-Traditional Acquisition Trajectories , 2011, IEEE Transactions on Nuclear Science.